Moshe Leshno

Medicine & Life Sciences

1. Cost-Benefit Analysis 100%
2. Decision Support Techniques 86%
3. Quality-Adjusted Life Years 65%
4. Israel 61%
5. Costs and Cost Analysis 52%
6. Electronic Health Records 44%
7. Population 38%
8. Clinical Decision-Making 37%
9. Milk Hypersensitivity 32%
10. Physicians 32%
11. Hospital Emergency Service 31%
12. Decision Making 26%
13. Chronic Hepatitis C 25%
14. Milk 25%
15. Milk Proteins 25%
16. Hepacivirus 24%
17. Celiac Disease 22%
18. Occult Blood 22%
19. Colorectal Neoplasms 21%
20. Survival 20%
21. Colonoscopy 20%
22. Health Information Exchange 20%
23. Adenoma 20%
24. Gastroesophageal Reflux 19%
25. Economics 19%
26. Fatty Liver 19%
27. Therapeutics 19%
28. Liver Transplantation 18%
29. Hepatitis C 18%
30. Hematologic Tests 18%
31. Mortality 18%
32. Neoplasms 17%
33. pembrolizumab 17%
34. Immunoglobulin E 17%
35. Nivolumab 17%
36. Trial of Labor 17%
37. Fibrosis 17%
38. Placebos 16%
39. Meta-Analysis 16%
40. Decision Trees 16%
41. Liver Cirrhosis 16%
42. Delivery of Health Care 15%
43. Child 15%
44. Neck Dissection 14%
45. Quality of Life 14%
46. Dyspepsia 14%
47. Odds Ratio 13%
48. Food Hypersensitivity 13%
49. Information Systems 13%
50. Food 13%